| 英文名称 |
中文名称 |
CAS |
|
ALOGLIPTIN(ALOG
LIPTINE, ALOGLIPTINA)
|
阿格列汀；阿洛利停;曲格列汀杂质T;2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氢-3-甲基-2,4-二氧Chemicalbook代-1(2H)-嘧啶基]甲基]苯甲腈(阿格列汀,又名:阿洛利停);苯甲酸阿格列汀原料药;苯甲酸阿格列汀中间体2 |
850649-61-5 |
|
Trelagliptin(syr472);Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-flChemicalbookuoro-;Trelagliptin(R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile;
|
曲格列汀；曲格列汀1;曲格列汀-INT E;曲格列汀;(R)-2-((6-(1-(3-胺哌啶基)-3-甲基-2,4-二氧杂-3,4-二氢吡啶基-1-(2H)-基)甲基)-4-氟苯甲氰 |
865759-25-7 |
|
CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib);Tasocitinib;3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550)
|
托法替尼；3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯[2,3-D]嘧啶-4-基)胺基)哌啶-1-基)-3-氧代丙腈; |
477600-75-2 |
|
BENZIMIDAVIR
|
马立巴韦；BENZIMIDAVIR 苯并咪唑核苷;苯并咪唑核苷; |
176161-24-3 |
|
1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL;
|
伊美格列明；IMEGLIMIN游离态;(+)-(9CI)-1,6-二氢-N,N,6-三甲基-1,3,5-三嗪-2,4-二胺;伊美格列明;依格列明;(2S)Chemicalbook-N6,N6,2-三甲基-1,2-二氢-1,3,5-三嗪-4,6-二胺;IMEGLIMIN(依美格列);依格列明/伊美格列明;化合物T22860 |
775351-65-0 |
|
linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;
|
利拉利汀；LINAGLIPTIN利拉利汀(BI-1356);利格利汀;欧唐宁;利拉利汀 1KG;利拉利汀API;利纳利汀;利拉利汀原料药;利格列汀 |
668270-12-0 |
|
AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
|
奥拉帕尼；PARP 抑制剂;4-[4-氟-3-(哌嗪-1-环丙基羰基)苄 基]-2H-酞嗪-1-酮; |
763113-22-0 |
|
Regorafenib;BAY 73-4506;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;
|
瑞戈非尼；瑞格菲尼无水物;瑞格菲尼及中间体;BAY 73-4506/ 瑞格非尼/ 4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;瑞格菲尼杂质; |
755037-03-7 |
|
Irbinitinib;Irbinitinib(ARRY380);Irbinitinib (ARRY-380,Tucatinib,ONT 380);IRBINITINIB (ARRY-380; ONT-380)
|
妥卡替尼；6-[5-[[[2-(甲磺酰基)乙基]氨基];HER2抑制剂(IRBINITINIB);中文名:妥卡替尼英文名:IRBINITINIB (ARRY-380); |
937263-43-9 |
|
TAK-385;Relugolix;Altropane;TKA-385 Relugolix;
|
瑞卢戈利；1-(4-(1-(2,6-二氟苄基)-5-((二甲基氨基)甲基)-3-(6-甲氧基哒嗪-3-基)-2,4-二氧-1,2,3,4-四氢噻吩并[2,3-D]嘧啶-6-基)苯基)-3-甲氧基脲, |
737789-87-6 |
|
SPRYCEL;BMS354825;DASATINIB (BMS 354825);CS-1968;
|
达沙替尼；5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]Chemicalbook氨基]-;DASA锡IB;达沙替尼无水物(N-6晶型)大粒径(D50=30-60);达沙替尼无水物(N-6晶型)粉末状; |
302962-49-8 |
|
Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351);
|
卡博替尼；XL184(博卡替尼);XL-184(卡博替尼);卡博替尼碱;卡博替尼 100MG; |
849217-68-1 |
|
AV951 (KRN951, Tivozanib) (stopped use since the patent issue);AV-951; KRN951; AV 951;AV951;CS-8;
|
替沃扎尼；N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-异恶唑基)脲; |
475108-18-0 |
|
Sorafenib free base for research;Sorafenib Free Base;Forafenib;Sorafenib free base(Bay43-9006);nexavar,sorafenib;BAY43-9006; NEXAVAR;Nexavar;Sorafenib-d4
|
索拉非尼；索拉非尼及中间体;所拉菲尼;SORAFENIB TOSYLATE 索拉非尼;RAF抑制剂;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;甲苯磺酸索拉替尼(替尼类);索拉替尼 |
284461-73-0 |
|
Nemorexant;Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]-;Daridorexant
|
奈莫雷生;达利多雷生 |
1505484-82-1 |
|
vitamine K;VITAMIN K;Synkavite;2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione;VITAMIN K1 USP23;
|
维生素K |
12001-79-5 |
|
E7080;LENVATINIB;E7080 (Lenvatinib);Lenvatinib (E7080);
|
乐伐替尼；乐伐替尼 4-[3-氯-4-(环丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺;伦瓦替尼;乐伐替尼游离碱;乐伐替尼 LENVATINIB;仑伐替尼 |
417716-92-8 |
|
KPT-330;(2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide;Selinexor;
|
Selinexor；塞利尼索;塞灵克斯;(Z)-3-(3-(3,5-双(三氟甲基)苯基)-1H-1,2,4-三唑-1-基)-N'-(吡嗪-2-基)丙烯酰肼 |
1393477-72-9 |
|
N-(2-Acetamido)iminodiacetic acid
|
乙酰氨基亚胺乙酸 |
26239-55-4 |
|
VX-770
|
依伐卡托 |
873054-44-5 |
|
n-methyl-3-(2-methylphenoxy)benzenepropanamine;(r)-tomoxetine;Tomoxetine;TomoxetineHcl;
|
托莫西汀；(R)-托莫西汀;(R)-N-甲基-3-(2-甲基苯氧)-3-苯丙胺;托莫西汀;托莫西汀杂质F;托莫西汀杂质G;托莫西汀杂质B EP标准品 |
83015-26-3 |
|
LOXO-101;CS-2322;LOXO101;LOXO 101;LOXO-101,LAROTRECTINIB,ARRY-470 (LAROTRECTINIB SULFATE CAS:1223405-08-0);
|
拉罗替尼；拉洛替尼;拉罗托西尼杂质;拉罗特里尼杂质;原肌球蛋白受体激酶抑制剂(TRK抑制剂)(LOXO-101); |
1223403-58-4 |
|
Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-B)pyridin-3-yl)-5-pyrimidinyl)methyl-, methyl ester;Riociguat (BAY 63-2521);Riocguat;CS-718;Riociguat, BZY 632521
|
利奥西胍；磺达肝癸钠中间体I(A-8);利奥西呱,BAY 63-2521;利奥西呱杂质(A-D);利奥西呱杂质D;利奥西呱(API);氘代盐酸利莫那班;利奥西呱 |
625115-55-1 |
|
AF-802;CH-5424802/RG-7853;Alectinib (CH5424802);AF 802; AF-802; AF802; CH5424802; CH5424802; CH 5424802; RO5424802; RO 5424802; RO5424802, ALECTINIB;
|
艾乐替尼 |
1256580-46-7 |
|
1-(4-Nitrophenyl)acetone;2-Propanone,1-(4-nitrophenyl)-;
|
4-硝基苯丙酮；4-硝基苯丙酮, |
5332-96-7 |
|
INTEDANIB BASE;Nintedanib;Nintedanib (BIBF 1120);Nintedanib/Intedanib/Vargatef;BIBF 1120; VARGATEF; INTEDANIB;INTEDANIB BASE;Intedanib Vargatef;Nintedanib-016;100837
|
尼达尼布；(3Z)-2,3-二氢-3-[[[4-[甲基[2-(4-甲基-1-哌嗪基)乙酰]氨基]苯基]氨基]苯亚甲基]-2-氧代-1H-吲哚-6-甲酸甲酯;尼达尼布乙烷磺酸盐;尼达尼布杂质(A-D) |
656247-17-5 |
|
LasMiditan;2,4,6-trifluoro-N-(6-(1-Methylpiperidine-4-carbonyl)pyridin-2-yl)benzaMide;COL-144; LY573144;CS-2381;COL-144; LY-573144;COL144; LY 573144;
|
拉米地坦；拉米迪坦;2,4,6-三氟-CHEMICALBOOKN-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺;拉米地坦/拉斯米地坦 |
439239-90-4 |
|
ACT 064992;ACT-064992;ACT-064992 / ACT064992;Macitentan, >=99%;
|
马西替坦；艾德拉尼中间体1;马西;马昔替坦;马西替坦 API;麦西腾坦 |
441798-33-0 |
|
entrecitinib;Entrectinib(RXDX-101)
|
恩曲替尼；恩曲替尼;TRK/ROS1/ALK抑制剂;恩曲替尼RXDX-101;RXDX-101恩曲替尼;NVP-LGK974, WNT974 |
1108743-60-7 |
|
Solriamfetol;(S)-2-amino-3-phenylpropyl carbamate hydrochloride
|
solriamfetol；索利氨酯 |
561069-23-6 |
|
AZD-9291
|
迈瑞替尼 |
1421373-65-0 |
|
Tetrabromophenol blue
|
四溴酚蓝 |
4430-25-5 |
|
aprocitentan
|
阿西替坦 |
1103522-45-7 |
|
sparsentan
|
司帕生坦 |
254740-64-2 |
|
Triisopropanolamine Borate
|
三异丙醇胺环硼酸盐 |
101-00-8 |
|
Undecylenoyl phenylalanine
|
十一碳烯酰基苯丙氨酸 |
175357-18-3 |
|
N(4)-hydroxycytidine
|
N-羟基胞苷 |
3258-02-4 |
|
2,5,6-TRICHLORO-1H-BENZIMIDAZOLE
|
2,5,6-三氯苯并咪唑 |
16865-11-5 |
|
Momelotinib
|
莫洛替尼 |
1056634-68-4 |
|
6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE
|
6-氯-3-异丙基嘧啶-2,4(1H,3H)-二酮 |
887581-47-7 |
|
2,4-Dichlorobenzenediazonium tetrafluoroborate
|
2,4二氯苯基重氮四氟硼酸盐 |
21872-70-8 |
|
Pirtobrutinib
|
LOXO-305 |
2101700-15-4 |
|
N-Desmethyl lmatinib
|
N-去甲基伊马替尼 |
404844-02-6 |
|
Masitinib
|
马赛替尼 |
790299-79-5 |
|
Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196;
|
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游离态;化合物MGL3196; |
920509-32-6 |
|
2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt
|
2-甲氧基-4-吗啉基重氮苯氯化锌盐 |
67801-08-5 |
|
4'-AMINOPROPIOPHENONE
|
4-胺基丙苯酮 |
70-69-9 |
|
Brexpiprazole
|
依匹哌唑 |
913611-97-9 |
|
Tri(4-morpholinyl)phosphine oxide
|
三(4-吗啉基)氧化膦 |
4441-12-7 |
|
Salcaprozate Sodium
|
8-（2-羟基苯甲酰胺基）辛酸钠 |
203787-91-1 |
|
ISOPROPYLUREA
|
异丙基脲 |
691-60-1 |
|
5',5''-Dinitro-3',3''-diiodo-3,4,5,6-trtrabromophenol-sulfonephthalein
|
5', 5''-二硝基-3', 3''-二碘基-3,4,5,6-四溴酚磺酞 |
145551-16-2 |
|
7-Chloro-[1,2,4]triazolo[1,5-a]pyridine
|
7-氯-[1,2,4]三唑并[1,5-A]吡啶 |
1427452-48-9 |
|
Trilaciclib
|
曲拉西利 |
1374743-00-6 |
|
TAK-788
|
莫博替尼 |
1847461-43-1 |
|
1,2,3,4-tetrahydro-benzo[h]quinolin-3-ol hydrochloride
|
1,2,3,4-四氢苯并喹啉-3-酚盐酸盐 |
73579-26-7 |
|
4-Aminopiperidine-4-carboxylic acid
|
4-氨基哌啶-4-羧酸 |
40951-39-1 |
|
Aripiprazole
|
阿立哌唑 |
129722-12-9 |
|
vericiguat
|
维利西呱 |
1350653-20-1 |
|
Ethyl Isocyanatoacetate
|
异氰酰乙酸乙酯 |
2949-22-6 |
|
reproxalap
|
REPROXALAP |
916056-79-6 |
|
3-(N-tosyl-L-alanyloxy)-indole
|
3-（N-对甲苯磺酰基-L-丙氨酰氧基）-吲哚 |
75062-54-3 |
|
2,6-Dichlorophenolindophenol sodium salt xhydrate
|
2,6-二氯靛酚 钠盐 水合物 |
1266615-56-8 |
|
Morpholine hydrochloride
|
吗啡啉盐酸盐 |
10024-89-2 |
|
Methyl Green
|
甲基绿 |
7114-03-6 |
